Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
4.090
+0.040 (0.99%)
Sep 16, 2025, 4:00 PM EDT - Market closed
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 5 analysts that cover Definitive Healthcare stock have a consensus rating of "Buy" and an average price target of $4.88, which forecasts a 19.32% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $7.00.
Price Target: $4.88 (+19.32%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 8, 2025.
Analyst Ratings
The average analyst rating for Definitive Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 6 | 6 | 6 | 4 | 3 |
| Sell | 2 | 2 | 2 | 2 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 10 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +46.70% | Aug 8, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $3 → $3.4 | Hold | Maintains | $3 → $3.4 | -16.87% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4.5 → $3 | Hold | Maintains | $4.5 → $3 | -26.65% | Mar 4, 2025 |
| Barclays | Barclays | Sell Maintains $4 → $3 | Sell | Maintains | $4 → $3 | -26.65% | Mar 3, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 16, 2025 |
Financial Forecast
Revenue This Year
245.58M
from 252.20M
Decreased by -2.63%
Revenue Next Year
247.24M
from 245.58M
Increased by 0.68%
EPS This Year
0.24
from -3.54
EPS Next Year
0.27
from 0.24
Increased by 13.55%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 251.6M | 267.9M | |
| Avg | 245.6M | 247.2M | |
| Low | 232.3M | 226.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.2% | 9.1% | |
| Avg | -2.6% | 0.7% | |
| Low | -7.9% | -7.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.25 | 0.41 | |
| Avg | 0.24 | 0.27 | |
| Low | 0.21 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 74.2% | |
| Avg | - | 13.5% | |
| Low | - | -16.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.